January 14, 2021
Features
41
1
With a complicated and challenging global picture greeting the new year, driven by the continuing pandemic and historic political and regulatory changes in the US and Europe, we outline eight diverse trends critical to biopharma’s future health and growth.
January 14, 2021
Features
41
1
How biopharma manufacturers can address extreme pricing of novel rare disease medicines and build legitimacy into commercialization to avoid an industrywide crisis.
January 14, 2021
Back Page
41
1
Data suggests physicians just as hesitant as patients, but recent successes could turn the tide.
January 13, 2021
Technology
41
1
Industry’s tardy shift to cloud-based solutions looks set to gather pace in 2021.
January 13, 2021
Sustainability
41
1
Biopharma sustainability resolutions for a better 2021.
January 13, 2021
Executive Profile
41
1
Deeply shaped by the experiences of his parents and an early charge to help drive social change, Global Blood Therapeutics’ Ted Love comes at sickle cell disease from a place of caring and urges pharma to follow suit to bring justice to all.
January 12, 2021
Issue PDF
41
1
Click the title above for a link to open the Pharmaceutical Executive January 2021 issue in an interactive PDF format.
January 12, 2021
Washington Report
41
1
Biden administration faces key decisions on drug testing and access amid vaccine distribution challenges.
January 12, 2021
From the Editor
41
1
Embracing the new, holistic views of pharma in 2021.
January 12, 2021
Leadership
41
1
The need to prioritize digital skill-building companywide.
January 12, 2021
Global Report
41
1
EU tasked with translating bold declarations into reality.
January 08, 2021
Finance
41
1
Tone still set on the market catalysts to look for in 2021.